Ventyx Biosciences (VTYX) Reports Q3 Results, Provides Business Update

Go back to Ventyx Biosciences (VTYX) Reports Q3 Results, Provides Business Update

Piper Sandler Starts Ventyx Biosciences Inc (VTYX) at Overweight

November 15, 2021 7:52 AM EST

Piper Sandler analyst Yasmeen Rahimi initiates coverage on Ventyx Biosciences Inc (NASDAQ: VTYX) with a Overweight rating and a price target of $50.00.

For an analyst ratings summary and ratings history on Ventyx Biosciences Inc... More

UPDATE: Evercore ISI Initiates Ventyx Biosciences Inc (VTYX) at Outperform (correction)

November 15, 2021 6:35 AM EST

(Updated - November 15, 2021 7:54 AM EST)

Evercore ISI analyst Josh Schimmer starts coverage on Ventyx Biosciences Inc (NASDAQ: VTYX) with Outperform rating, PT $50.00.

... More

UPDATE: Jefferies Starts Ventyx Biosciences Inc (VTYX) at Buy

November 15, 2021 4:53 AM EST

(Updated - November 15, 2021 7:51 AM EST)

Jefferies analyst Michael Yee initiates coverage on Ventyx Biosciences Inc (NASDAQ: VTYX) with a Buy rating and a price target of $30.00.

The analyst commented, "We initiate on VTYX at Buy with a $30 PT based on... More